CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction Dilated cardiomyopathy: so many cardiomyopathies! Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled Study

Original ResearchCirculation. 2018;139:489–501

JOURNAL:Circulation. Article Link

Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery

Aragam KG, Chaffin M, GRADE Investigators. Keywords: nonischemic cardiomyopathy; genetic discovery, heart failure; CAD; atrial fibrillation

FULL TEXT PDF